These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11094439)

  • 1. What you should know about PR3-ANCA. Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA.
    Specks U
    Arthritis Res; 2000; 2(4):263-7. PubMed ID: 11094439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of carboxy-terminal modifications of proteinase 3 (PR3) on the recognition by PR3-ANCA.
    Capizzi SA; Viss MA; Hummel AM; Fass DN; Specks U
    Kidney Int; 2003 Feb; 63(2):756-60. PubMed ID: 12631144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide.
    Sun J; Fass DN; Viss MA; Hummel AM; Tang H; Homburger HA; Specks U
    Clin Exp Immunol; 1998 Nov; 114(2):320-6. PubMed ID: 9822293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.
    van der Geld YM; Oost-Kort W; Limburg PC; Specks U; Kallenberg CG
    J Immunol Methods; 2000 Oct; 244(1-2):117-31. PubMed ID: 11033024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA; Fass DN; Specks U
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and functional expression of the murine homologue of proteinase 3: implications for the design of murine models of vasculitis.
    Jenne DE; Fröhlich L; Hummel AM; Specks U
    FEBS Lett; 1997 May; 408(2):187-90. PubMed ID: 9187364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes.
    Sun J; Fass DN; Hudson JA; Viss MA; Wieslander J; Homburger HA; Specks U
    J Immunol Methods; 1998 Feb; 211(1-2):111-23. PubMed ID: 9617836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener's autoantigen.
    Silva F; Hummel AM; Jenne DE; Specks U
    J Autoimmun; 2010 Dec; 35(4):299-308. PubMed ID: 20810247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What you should know about PR3-ANCA. Structural aspects of antibodies to proteinase 3 (PR3).
    Peen E; Williams RC
    Arthritis Res; 2000; 2(4):255-9. PubMed ID: 11094437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases.
    Lee AS; Finkielman JD; Peikert T; Hummel AM; Viss MA; Specks U
    J Immunol Methods; 2005 Dec; 307(1-2):62-72. PubMed ID: 16242707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
    van der Geld YM; Tool AT; Videler J; de Haas M; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG; Roos D
    Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional significance of Asn-linked glycosylation of proteinase 3 for enzymatic activity, processing, targeting, and recognition by anti-neutrophil cytoplasmic antibodies.
    Specks U; Fass DN; Finkielman JD; Hummel AM; Viss MA; Litwiller RD; McDonald CJ
    J Biochem; 2007 Jan; 141(1):101-12. PubMed ID: 17158864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of conformational restraints on reactivity of human PR3-specific autoantibodies (ANCA) facilitated through protein folding manipulations of a new recombinant proteinase 3 protein.
    Farrag L; Pendergraft WF; Yang JJ; Jennette JC; Falk RJ; Preston GA
    Autoimmunity; 2007 Nov; 40(7):503-11. PubMed ID: 17966040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
    Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG
    Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis.
    Daouk GH; Palsson R; Arnaout MA
    Kidney Int; 1995 Jun; 47(6):1528-36. PubMed ID: 7643521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the processing and granular targeting of human proteinase 3 after transfection to the rat RBL or the murine 32D leukemic cell lines.
    Garwicz D; Lindmark A; Hellmark T; Gladh M; Jögi J; Gullberg U
    J Leukoc Biol; 1997 Jan; 61(1):113-23. PubMed ID: 9000544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of PR3-ANCA epitope specificity in Wegener's granulomatosis. Analysis using the biosensor technology.
    Rarok AA; van der Geld YM; Stegeman CA; Limburg PC; Kallenberg CG
    J Clin Immunol; 2003 Nov; 23(6):460-8. PubMed ID: 15031633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a recombinant proteinase 3, the autoantigen in Wegener's granulomatosis and its reactivity with anti-neutrophil cytoplasmic autoantibodies.
    Witko-Sarsat V; Halbwachs-Mecarelli L; Almeida RP; Nusbaum P; Melchior M; Jamaleddine G; Lesavre P; Descamps-Latscha B; Gabay JE
    FEBS Lett; 1996 Mar; 382(1-2):130-6. PubMed ID: 8612734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site.
    Griffith ME; Coulthart A; Pemberton S; George AJ; Pusey CD
    Clin Exp Immunol; 2001 Jan; 123(1):170-7. PubMed ID: 11168015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.